In BC, CTLA-4 is a co-suppressor receptor molecule expressed on activated T cells and Tregs that interacts with the B7-1 (CD80)/B7-2 (CD86) ligand-binding site on antigen-presenting cells (APCs), and competes with CD28 to negatively regulate T cells [152,153]. The gene discussed is CD86; the disease is breast cancer.